Loading clinical trials...
Loading clinical trials...
Kuvan® (Sapropterin Dihydrochloride) for Improving Gastric Accommodation in Women With Diabetic Gastroparesis (KIGA-DG)
Conditions
Interventions
sapropterin dihydrochloride
Locations
1
United States
Stanford University School of Medicine
Stanford, California, United States
Start Date
May 1, 2010
Primary Completion Date
November 1, 2012
Completion Date
November 1, 2012
Last Updated
September 10, 2019
NCT03876288
NCT06803589
NCT06046833
NCT04287647
NCT05621811
NCT03531450
Lead Sponsor
Stanford University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions